Incy (INCY) Shareholder Jgp Global Gestao De Recursos Ltda Has Cut Its Stake; H Partners Management Has Upped Holding in Tempur Sealy Intl (TPX) as Shares Rose

Incyte Corporation (NASDAQ:INCY) Logo

Jgp Global Gestao De Recursos Ltda decreased its stake in Incy (INCY) by 46.03% based on its latest 2018Q2 regulatory filing with the SEC. Jgp Global Gestao De Recursos Ltda sold 9,402 shares as the company’s stock declined 5.71% while stock markets rallied. The institutional investor held 11,025 shares of the commercial physical & biological resarch company at the end of 2018Q2, valued at $739,000, down from 20,427 at the end of the previous reported quarter. Jgp Global Gestao De Recursos Ltda who had been investing in Incy for a number of months, seems to be less bullish one the $13.94 billion market cap company. The stock decreased 4.10% or $2.8 during the last trading session, reaching $65.52. About 1.96 million shares traded or 28.67% up from the average. Incyte Corporation (NASDAQ:INCY) has declined 45.99% since December 6, 2017 and is downtrending. It has underperformed by 61.61% the S&P500. Some Historical INCY News: 13/03/2018 – MERCK & CO INC – SBLA FOR KEYTRUDA IS BASED IN PART ON DATA FROM PHASE 2 KEYNOTE-158 TRIAL; 06/04/2018 – NewLink Will Review Clinical Programs After Merck, Incyte Trial Failure — MarketWatch; 18/04/2018 – U.S. FDA Accepts Supplemental Biologics License Application for Opdivo (nivolumab) in Previously Treated Patients With Small Cell Lung Cancer and Grants Priority Review; 16/04/2018 – BIOTHERA PHARMACEUTICALS PRESENTS TRANSLATIONAL DATA FROM ONGOING CLINICAL TRIALS SHOWING IMPRIME PGG IN COMBINATION WITH MERCK’S KEYTRUDA® (PEMBROLIZUMAB) DRIVES INNATE AND ADAPTIVE IMMUNE…; 02/04/2018 – Aeglea BioTherapeutics Doses First Small Cell Lung Cancer Patients With Pegzilarginase in Both Monotherapy and KEYTRUDA Combination Trials; 19/04/2018 – Good news for $GLPG $GILD $ABBV is that FDA sees thrombosis as a unique issue with $INCY $LLY baricitinib and not seen with other JAKi; 23/05/2018 – Merck’s KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line; 06/04/2018 – Incyte and Merck Provide Update on Phase 3 Study of Epacadostat in Combination with KEYTRUDA® (pembrolizumab) in Patients with Unresectable or Metastatic Melanoma; 19/04/2018 – FDA STAFF – WITHOUT ADVANTAGE OVER AVAILABLE THERAPIES, LILLY WILL NEED TO EXPLORE WHETHER LOWER DOSE OF ITS RHEUMATOID ARTHRITIS TREATMENT CAN PROVIDE EFFICACY WITHOUT SAFETY CONCERN OF THROMBOSIS…; 08/05/2018 – ONCOSEC EXPANDS RELATIONSHIP WITH MERCK, ANNOUNCES CLINICAL COLLABORATION TO EVALUATE COMBINATION OF IMMUNOPULSE IL-12 AND KEYTRUDA FOR TRIPLE NEGATIVE BREAST CANCER

H Partners Management Llc increased its stake in Tempur Sealy Intl Inc (TPX) by 9.42% based on its latest 2018Q2 regulatory filing with the SEC. H Partners Management Llc bought 688,800 shares as the company’s stock rose 6.29% with the market. The hedge fund held 8.00M shares of the consumer durables company at the end of 2018Q2, valued at $384.40 million, up from 7.31M at the end of the previous reported quarter. H Partners Management Llc who had been investing in Tempur Sealy Intl Inc for a number of months, seems to be bullish on the $2.79B market cap company. The stock decreased 4.30% or $2.3 during the last trading session, reaching $51.16. About 1.77M shares traded or 88.48% up from the average. Tempur Sealy International, Inc. (NYSE:TPX) has declined 11.01% since December 6, 2017 and is downtrending. It has underperformed by 26.63% the S&P500. Some Historical TPX News: 09/05/2018 – TEMPUR SEALY HOLDER H PARTNERS RAISES STAKE TO 14.72%; 14/05/2018 – Iconiq Adds Lam Research, Exits Tempur Sealy: 13F; 15/05/2018 – Vulcan Value Partners Buys New 1.1% Position in Tempur Sealy; 20/03/2018 S&PGR Affirms Tempur Sealy Intl Rtg, Otlk Remains Negative; 15/05/2018 – Entrustpermal Partners Offshore Buys 2% of Tempur Sealy; 03/05/2018 – Tempur Sealy 1Q EPS 42c; 03/05/2018 – TEMPUR SEALY 1Q ADJ EPS 42C, EST. 47C; 26/03/2018 – TEMPUR SEALY IN LETTER WITH DIRECTOR NABI, H PARTNERS; 26/03/2018 – TEMPUR SEALY: H PARTNERS TO VOTE IN FAVOR OF CO. DIRECTORS; 26/03/2018 – TEMPUR SEALY AGREED TO NOMINATE H PARTNERS PARTNER RUCHIM TO BD

More notable recent Incyte Corporation (NASDAQ:INCY) news were published by: Streetinsider.com which released: “Incyte (INCY) Announces Results of REACH1 Study of Ruxolitinib for Treatment of Acute GVHD Demonstrate Rapid and Durable Patient Benefit – StreetInsider.com” on December 03, 2018, also Nasdaq.com with their article: “Why Is Incyte (INCY) Up 1.5% Since Last Earnings Report? – Nasdaq” published on November 29, 2018, Benzinga.com published: “Garmin Ltd. (NASDAQ:GRMN), Incyte Corporation (NASDAQ:INCY) – 5 Stocks To Have On Your Radar Next Week – Benzinga” on September 07, 2018. More interesting news about Incyte Corporation (NASDAQ:INCY) were released by: Benzinga.com and their article: “Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials, IPOs (Dec. 2-8) – Benzinga” published on December 02, 2018 as well as Nasdaq.com‘s news article titled: “Merck’s (MRK) Keytruda Gets FDA Approval for Liver Cancer – Nasdaq” with publication date: November 12, 2018.

Jgp Global Gestao De Recursos Ltda, which manages about $62.47 million US Long portfolio, upped its stake in Bud (NYSE:BUD) by 19,100 shares to 61,313 shares, valued at $6.18M in 2018Q2, according to the filing.

Among 30 analysts covering Incyte (NASDAQ:INCY), 20 have Buy rating, 0 Sell and 10 Hold. Therefore 67% are positive. Incyte had 103 analyst reports since August 6, 2015 according to SRatingsIntel. Vetr upgraded the stock to “Hold” rating in Monday, September 7 report. The rating was initiated by Goldman Sachs with “Buy” on Wednesday, November 18. The company was maintained on Tuesday, August 18 by Piper Jaffray. The stock of Incyte Corporation (NASDAQ:INCY) earned “Hold” rating by Gabelli on Monday, April 9. Cantor Fitzgerald maintained the shares of INCY in report on Monday, October 22 with “Neutral” rating. The rating was maintained by Argus Research on Monday, September 26 with “Buy”. The firm earned “Equal-Weight” rating on Friday, July 13 by Morgan Stanley. The stock of Incyte Corporation (NASDAQ:INCY) has “Buy” rating given on Monday, June 5 by BMO Capital Markets. The rating was downgraded by Zacks to “Buy” on Wednesday, August 12. As per Tuesday, July 25, the company rating was maintained by Oppenheimer.

Investors sentiment increased to 1.23 in Q2 2018. Its up 0.01, from 1.22 in 2018Q1. It is positive, as 73 investors sold INCY shares while 101 reduced holdings. 52 funds opened positions while 162 raised stakes. 183.44 million shares or 3.60% less from 190.28 million shares in 2018Q1 were reported. Opus Point Partners Mngmt Ltd Llc, a New York-based fund reported 12,321 shares. Cornerstone Advsrs holds 57 shares. New Mexico Educational Retirement Board owns 16,200 shares. Jennison Associates Limited Liability Company owns 645,183 shares. Tradewinds Capital Management Limited Liability Corp owns 200 shares. Moreover, Blackrock Incorporated has 0.04% invested in Incyte Corporation (NASDAQ:INCY) for 14.48 million shares. Tiverton Asset Mngmt Limited Liability Corporation reported 6,899 shares stake. Eaton Vance Mngmt owns 177,071 shares. Grandfield & Dodd Ltd Liability Company has invested 0.06% in Incyte Corporation (NASDAQ:INCY). New York State Teachers Retirement reported 0.04% stake. Rock Springs Cap Management L P, Maryland-based fund reported 296,000 shares. Cambiar Limited holds 0.08% or 68,226 shares in its portfolio. 20 are held by Baystate Wealth Mngmt Ltd Liability Corp. Proshare Ltd invested 0.1% of its portfolio in Incyte Corporation (NASDAQ:INCY). Bnp Paribas Arbitrage holds 184,087 shares or 0% of its portfolio.

Since July 9, 2018, it had 1 buying transaction, and 7 selling transactions for $3.59 million activity. Shares for $711,100 were sold by SWAIN PAULA J. Trower Paul also sold $700,000 worth of Incyte Corporation (NASDAQ:INCY) shares. On Thursday, November 8 the insider BIENAIME JEAN JACQUES bought $68,765. Another trade for 1,000 shares valued at $70,000 was made by Flannelly Barry P on Wednesday, October 3.

Analysts await Incyte Corporation (NASDAQ:INCY) to report earnings on February, 21. They expect $0.31 earnings per share, up 1,450.00% or $0.29 from last year’s $0.02 per share. INCY’s profit will be $65.97 million for 52.84 P/E if the $0.31 EPS becomes a reality. After $0.20 actual earnings per share reported by Incyte Corporation for the previous quarter, Wall Street now forecasts 55.00% EPS growth.

Investors sentiment decreased to 0.96 in 2018 Q2. Its down 0.01, from 0.97 in 2018Q1. It turned negative, as 34 investors sold TPX shares while 61 reduced holdings. 25 funds opened positions while 66 raised stakes. 63.08 million shares or 8.29% more from 58.25 million shares in 2018Q1 were reported. Thrivent Fincl For Lutherans owns 10,535 shares for 0% of their portfolio. State Of Wisconsin Board reported 9,090 shares or 0% of all its holdings. Gp One Trading Limited Partnership holds 0.01% of its portfolio in Tempur Sealy International, Inc. (NYSE:TPX) for 13,901 shares. Salem Invest Counselors owns 8,550 shares. California Public Employees Retirement Systems holds 0.01% or 108,241 shares. Riverhead Cap Mgmt Ltd Limited Liability Company accumulated 0.01% or 6,252 shares. Bnp Paribas Arbitrage Sa has 0% invested in Tempur Sealy International, Inc. (NYSE:TPX) for 26,381 shares. Financial Bank Of New York Mellon, New York-based fund reported 596,860 shares. Panagora Asset has 3,310 shares. Raymond James And Assoc stated it has 0.01% of its portfolio in Tempur Sealy International, Inc. (NYSE:TPX). Jane Street Grp Inc Limited Liability Company holds 0% of its portfolio in Tempur Sealy International, Inc. (NYSE:TPX) for 31,686 shares. Credit Suisse Ag accumulated 114,981 shares or 0.01% of the stock. Citigroup has invested 0% in Tempur Sealy International, Inc. (NYSE:TPX). Oregon Pub Employees Retirement Fund stated it has 0.01% in Tempur Sealy International, Inc. (NYSE:TPX). Ironwood Investment Management Limited Liability Com holds 0.59% or 17,318 shares.

More notable recent Tempur Sealy International, Inc. (NYSE:TPX) news were published by: Benzinga.com which released: “Piper Jaffray Lowers Tempur Sealy (NYSE:TPX) Price Target, Says Mattress Firm Gained Market Share With ‘Aggressive’ Promotions – Benzinga” on March 12, 2018, also Fool.ca with their article: “Canopy Growth Corp. (TSX:WEED) and HEXO Corp. (TSX:HEXO) Could Take Off Once Cannabis-Infused Beverages Hit Store Shelves – The Motley Fool Canada” published on November 23, 2018, Benzinga.com published: “Bullish KeyBanc Sees Opportunity For Tempur Sealy (NYSE:TPX) In A Mattress Firm Bankruptcy – Benzinga” on August 23, 2018. More interesting news about Tempur Sealy International, Inc. (NYSE:TPX) were released by: Seekingalpha.com and their article: “Tempur Sealy talks Sears bankruptcy – Seeking Alpha” published on October 16, 2018 as well as Seekingalpha.com‘s news article titled: “Tempur Sealy International (TPX) Q2 2018 Results – Earnings Call Transcript – Seeking Alpha” with publication date: July 26, 2018.

Incyte Corporation (NASDAQ:INCY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.